ES8802249A1 - Un procedimiento para el aislamiento de un gen de relaxina de un ser humano u otro primate o de una especie relacionada - Google Patents
Un procedimiento para el aislamiento de un gen de relaxina de un ser humano u otro primate o de una especie relacionadaInfo
- Publication number
- ES8802249A1 ES8802249A1 ES544293A ES544293A ES8802249A1 ES 8802249 A1 ES8802249 A1 ES 8802249A1 ES 544293 A ES544293 A ES 544293A ES 544293 A ES544293 A ES 544293A ES 8802249 A1 ES8802249 A1 ES 8802249A1
- Authority
- ES
- Spain
- Prior art keywords
- relaxin
- gene
- human
- chain
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- BJRCFZKVYNDCJE-WBSNEMHCSA-N 99489-95-9 Chemical compound C([C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N2)[C@@H](C)CC)=O)CSSC[C@@H](C(NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC1=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCNC(N)=N)C(C)C)C1=CC=C(O)C=C1 BJRCFZKVYNDCJE-WBSNEMHCSA-N 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 238000012512 characterization method Methods 0.000 title 1
- 238000010369 molecular cloning Methods 0.000 title 1
- 239000013598 vector Substances 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 108090000103 Relaxin Proteins 0.000 abstract 2
- 101001091088 Homo sapiens Prorelaxin H2 Proteins 0.000 abstract 1
- 241000288906 Primates Species 0.000 abstract 1
- 102000003743 Relaxin Human genes 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000009396 hybridization Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/64—Relaxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Reproductive Health (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
PROCEDIMIENTO PARA EL AISLAMIENTO DE UN GEN DE RELAXINA DE UN SER HUMANO U OTRO PRIMATE O DE UNA ESPECIE RELACIONADA, EN QUE: A) AISLAR MARN; B) PREPARAR ADN DE DOBLE CADENA (CADN) A PARTIR DEL MARN; C) INSERTAR EL CADN EN UN VECTOR DE TRANSFERENCIA APROPIADO PARA DAR UN VECTOR DE TRANSFERENCIA RECOMBINANTE; D) TRANSFORMAR CELULAS HOSPEDANTES CON LOS VECTORES DE TRANSFERENCIA RECOMBINANTES; Y E) HIBRIDAR LOS VECTORES DE TRANSFERENCIA RECOMBINANTES CON UNA SONDA DE HIBRIDACION MARCADA CORRESPONDIENTE A UNA SUBUNIDAD O FRAGMENTO DEL GEN DE RELAXINA -H2 HUMANA, QUE COMPRENDE NUCLEOTIDOS DE LA REGION DE CODIFICACION DEL PEPTIDO G/PEPTIDO A DEL ADN, PARA IDENTIFICAR UN GEN QUE CONTIENE RELAXINA, Y AISLAR DICHO GEN. TIENE APLICACION EN LA PRODUCCION DE RELAXINA HUMANA CON FINES TERAPEUTICOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPF724782 | 1982-12-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES544293A0 ES544293A0 (es) | 1988-04-16 |
| ES8802249A1 true ES8802249A1 (es) | 1988-04-16 |
Family
ID=3769889
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES527964A Expired ES8602133A1 (es) | 1982-12-13 | 1983-12-12 | Un procedimiento para preparar un vector de transferencias de adn |
| ES544293A Expired ES8802249A1 (es) | 1982-12-13 | 1985-06-17 | Un procedimiento para el aislamiento de un gen de relaxina de un ser humano u otro primate o de una especie relacionada |
| ES552095A Expired ES8801373A1 (es) | 1982-12-13 | 1986-02-17 | Un procedimiento para aislar un gen de preprorrelaxina -h2 humana o un equivalente o subunidad del mismo |
| ES552094A Expired ES8708015A1 (es) | 1982-12-13 | 1986-02-17 | Un procedimiento para preparar relaxina -h2 humana o uno de sus analogos |
| ES552093A Expired ES8708016A1 (es) | 1982-12-13 | 1986-02-17 | Un procedimiento para sintetizar una secuencia de aminoacidos que contienen la totalidad o parte de la secuencia de aminoacidos de la preprorrelaxina -h2 humana. |
| ES557531A Expired ES8801675A1 (es) | 1982-12-13 | 1987-05-11 | Un procedimiento para preparar relaxina-h2 humana |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES527964A Expired ES8602133A1 (es) | 1982-12-13 | 1983-12-12 | Un procedimiento para preparar un vector de transferencias de adn |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES552095A Expired ES8801373A1 (es) | 1982-12-13 | 1986-02-17 | Un procedimiento para aislar un gen de preprorrelaxina -h2 humana o un equivalente o subunidad del mismo |
| ES552094A Expired ES8708015A1 (es) | 1982-12-13 | 1986-02-17 | Un procedimiento para preparar relaxina -h2 humana o uno de sus analogos |
| ES552093A Expired ES8708016A1 (es) | 1982-12-13 | 1986-02-17 | Un procedimiento para sintetizar una secuencia de aminoacidos que contienen la totalidad o parte de la secuencia de aminoacidos de la preprorrelaxina -h2 humana. |
| ES557531A Expired ES8801675A1 (es) | 1982-12-13 | 1987-05-11 | Un procedimiento para preparar relaxina-h2 humana |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4758516A (es) |
| EP (2) | EP0303033B1 (es) |
| JP (3) | JP2545055B2 (es) |
| KR (1) | KR940002536B1 (es) |
| AT (2) | ATE62507T1 (es) |
| CA (1) | CA1220735A (es) |
| DE (1) | DE3382249D1 (es) |
| DK (2) | DK171684B1 (es) |
| ES (6) | ES8602133A1 (es) |
| HU (1) | HU197767B (es) |
| IE (1) | IE63902B1 (es) |
| IL (1) | IL70414A (es) |
| NZ (1) | NZ206534A (es) |
| ZA (1) | ZA839231B (es) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0101309B1 (en) * | 1982-08-12 | 1991-01-16 | Howard Florey Institute Of Experimental Physiology And Medicine | Molecular cloning and characterization of a gene sequence coding for human relaxin |
| US5179195A (en) * | 1982-12-13 | 1993-01-12 | Howard Florey Institute Of Experimental Physiology And Medicine | Human relaxin polypeptides |
| US4835251A (en) * | 1986-06-23 | 1989-05-30 | Genetech, Inc. | Method of chain combination |
| EP0260149A1 (en) * | 1986-09-12 | 1988-03-16 | Howard Florey Institute Of Experimental Physiology And Medicine | Human prorelaxin for therapeutic use |
| WO1989007945A1 (en) * | 1988-02-26 | 1989-09-08 | Genentech, Inc. | Human relaxin formulation |
| CA2051375C (en) * | 1989-05-04 | 2000-09-12 | Dennis J. Henner | Process and compositions for the isolation of human relaxin |
| US5089419A (en) * | 1989-08-07 | 1992-02-18 | International Canine Genetics | Detection of pregnancy by identification of the c peptide of relaxin in the urine of animals |
| US5166191A (en) * | 1991-08-19 | 1992-11-24 | Genentech, Inc. | Use of relaxin in cardiovascular therapy |
| US5478807A (en) * | 1991-08-19 | 1995-12-26 | Genentech, Inc. | Use of relaxin in the treatment of bradycardia |
| AU3123393A (en) * | 1991-10-28 | 1993-06-07 | Board Of Regents, The University Of Texas System | A method for detecting a differentiation marker in normal and carcinoma cells and in biological samples and body fluid |
| US6348327B1 (en) | 1991-12-06 | 2002-02-19 | Genentech, Inc. | Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells |
| CA2165781C (en) * | 1993-06-21 | 2007-02-13 | Tim Breece | Process for producing relaxin |
| US20050032683A1 (en) | 2000-10-04 | 2005-02-10 | Amento Edward P. | Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| US20040006205A1 (en) * | 2001-04-03 | 2004-01-08 | Li Li | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| CA2456753A1 (en) * | 2001-08-17 | 2003-02-27 | The Board Of Trustees Of The Leland Stanford Junior University | Mammalian relaxin receptors |
| AU2003903124A0 (en) * | 2003-06-20 | 2003-07-10 | Mark Del Borgo | Analogues of heteromeric proteins |
| WO2005115435A2 (en) * | 2004-04-30 | 2005-12-08 | Bas Medical, Inc. | Methods and compositions for control of fetal growth via modulation of relaxin |
| US20060052304A1 (en) * | 2004-09-02 | 2006-03-09 | Bas Medical, Inc. | Method for remodeling bone and related sutures |
| CN102026650A (zh) * | 2008-05-16 | 2011-04-20 | 科尔泰拉公司 | 预防早产的方法 |
| GR1006941B (el) | 2009-06-01 | 2010-08-27 | Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), | Πεπτιδικη συνθεση (peptide synthesis) |
| US8389475B2 (en) | 2009-08-10 | 2013-03-05 | The Board Of Trustees Of The Leland Stanford Junior University | Relaxin analogs |
| PE20140160A1 (es) | 2010-08-17 | 2014-02-08 | Ambrx Inc | Polipeptidos de relaxina modificados y sus usos |
| AU2012280474A1 (en) | 2011-07-01 | 2014-01-16 | Bayer Intellectual Property Gmbh | Relaxin fusion polypeptides and uses thereof |
| EP2630964A1 (en) | 2012-02-22 | 2013-08-28 | Immundiagnostik AG | Method and medicament for treating patients in risk of prediabetes and type-2 diabetes |
| WO2015073727A1 (en) | 2013-11-13 | 2015-05-21 | Aequus Biopharma, Inc. | Engineered glycoproteins and uses thereof |
| EP2946788A1 (en) | 2014-05-23 | 2015-11-25 | Immundiagnostik AG | Method and composition for treating heart failure with preserved ejection fraction |
| CN115837014A (zh) | 2016-05-18 | 2023-03-24 | 摩登纳特斯有限公司 | 编码松弛素的多核苷酸 |
| SG10201912034UA (en) | 2017-02-08 | 2020-02-27 | Bristol Myers Squibb Co | Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468464A (en) * | 1974-11-04 | 1984-08-28 | The Board Of Trustees Of The Leland Stanford Junior University | Biologically functional molecular chimeras |
| GR70279B (es) * | 1979-09-12 | 1982-09-03 | Univ California | |
| US4267101A (en) * | 1980-02-01 | 1981-05-12 | Serono Laboratories Inc. | Process for obtaining human relaxin from fetal membranes |
| EP0068375A3 (en) * | 1981-06-22 | 1983-04-13 | G.D. Searle & Co. | Recombinant dna techniques for the production of relaxin |
| IE55479B1 (en) * | 1982-02-12 | 1990-09-26 | Florey Howard Inst | Molecular cloning and characterization of the gene sequence coding for porcine relaxin |
| EP0101309B1 (en) * | 1982-08-12 | 1991-01-16 | Howard Florey Institute Of Experimental Physiology And Medicine | Molecular cloning and characterization of a gene sequence coding for human relaxin |
-
1983
- 1983-12-09 IL IL70414A patent/IL70414A/xx not_active IP Right Cessation
- 1983-12-09 NZ NZ206534A patent/NZ206534A/en unknown
- 1983-12-12 EP EP88110103A patent/EP0303033B1/en not_active Expired - Lifetime
- 1983-12-12 IE IE290883A patent/IE63902B1/en not_active IP Right Cessation
- 1983-12-12 DE DE8383307553T patent/DE3382249D1/de not_active Expired - Lifetime
- 1983-12-12 EP EP83307553A patent/EP0112149B1/en not_active Expired - Lifetime
- 1983-12-12 ES ES527964A patent/ES8602133A1/es not_active Expired
- 1983-12-12 ZA ZA839231A patent/ZA839231B/xx unknown
- 1983-12-12 AT AT83307553T patent/ATE62507T1/de not_active IP Right Cessation
- 1983-12-12 CA CA000443049A patent/CA1220735A/en not_active Expired
- 1983-12-12 AT AT88110103T patent/ATE90360T1/de not_active IP Right Cessation
- 1983-12-13 JP JP58233744A patent/JP2545055B2/ja not_active Expired - Lifetime
- 1983-12-13 KR KR1019830005905A patent/KR940002536B1/ko not_active Expired - Lifetime
- 1983-12-13 HU HU834243A patent/HU197767B/hu unknown
- 1983-12-13 US US06/560,790 patent/US4758516A/en not_active Expired - Lifetime
- 1983-12-13 DK DK573783A patent/DK171684B1/da not_active IP Right Cessation
-
1985
- 1985-06-17 ES ES544293A patent/ES8802249A1/es not_active Expired
-
1986
- 1986-02-17 ES ES552095A patent/ES8801373A1/es not_active Expired
- 1986-02-17 ES ES552094A patent/ES8708015A1/es not_active Expired
- 1986-02-17 ES ES552093A patent/ES8708016A1/es not_active Expired
-
1987
- 1987-05-11 ES ES557531A patent/ES8801675A1/es not_active Expired
-
1992
- 1992-11-30 DK DK143492A patent/DK172012B1/da not_active IP Right Cessation
-
1993
- 1993-03-22 JP JP5061747A patent/JP2677332B2/ja not_active Expired - Lifetime
-
1994
- 1994-10-26 JP JP6262254A patent/JP2891882B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8801373A1 (es) | Un procedimiento para aislar un gen de preprorrelaxina -h2 humana o un equivalente o subunidad del mismo | |
| ES8802160A1 (es) | Un procedimiento para aislar un gen de relaxina cromosomica de un ser humano o de otro primate o una especie afin | |
| IL86480A (en) | Recombinant dna coding for human proapolipoprotein a-1,expression vectors containing it and cells transformed by said expression vector | |
| CO2020015707A2 (es) | Casetes de expresión de α-glucosidasa de ácido optimizado con codón y métodos de uso del mismo | |
| PT1548032E (pt) | Péptidos kdr e vacinas que os contêm | |
| CL2020000295A1 (es) | Métodos de terapia génica del factor viii (fviii) | |
| NO176884C (no) | DNA-sekvens kodende for human Mangansuperoksyddismutase (hMn-SOD), vektorer inneholdende dette genet og rekombinant framstilling av hMn-SOD | |
| CO2023000444A2 (es) | Terapia génica usando constructos de ácido nucleico que comprenden secuencias promotoras del gen de la proteína 2 de unión a metil cpg (mecp2) | |
| DE69840333D1 (de) | 2-m übergang des zellzyklus | |
| ES2116683T3 (es) | Gen de la beta-galactosidasa hipertermoestable. | |
| MX2023001397A (es) | Variantes de fitasa y polinucleotidos que codifican las mismas. | |
| NO20062948L (no) | Promotere for ekspresjon i modifisert vaccinia-virus Ankara | |
| DK0843731T3 (da) | Adenovirusvektorer til genterapi | |
| DE69426121D1 (de) | Gen grb3-3, variante und ihre verwendungen | |
| DK1352056T3 (da) | Polypeptider, der er i stand til at fremkalde en immunreaktion mod cancer | |
| ES2059330T3 (es) | Un cdna codificador de antigeno carcinoembrionico. | |
| MX2024013891A (es) | Vacunas y métodos para usarlas para tratar cáncer relacionado con wnt | |
| PE20000759A1 (es) | Gen de la citocroma oxidasa de hidroquinona del tipo bd | |
| DE3380495D1 (en) | Molecular cloning and characterization of the gene sequence coding for porcine relaxin | |
| AR124143A1 (es) | Método para tratar la distrofia muscular mediante el direccionamiento al gen dmpk | |
| UY24341A1 (es) | Genes para la sintesis de sustancias antipatogenicas | |
| PE20242117A1 (es) | Acido nucleico optimizado por codones que codifica la proteina del factor de coagulacion ix, y su uso | |
| GT198304126A (es) | Produccion de proteinas del virus de herpes simplex |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19991007 |